© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Uracil traces its discovery to the late 19th century, when chemists wrestled with the composition of nucleic acids. Albrecht Kossel, an early pioneer in biochemical research, isolated uracil from yeast nuclein in 1900. This moment expanded the world’s understanding of RNA long before the double helix became common knowledge. People didn’t realize how central uracil’s simple ring structure would turn out: it crops up wherever cells summon genetic instructions into action. Over time, uracil’s detection and synthesis moved from benchwork to textbook content as standardized tools joined the laboratory, opening the door for generations of biochemists.
Uracil shows up everywhere RNA does. Its chemical formula—C4H4N2O2—packs four carbons, four hydrogens, two nitrogens, and two oxygens into a neat pyrimidine ring. People see the white crystalline powder and may not realize its value until it enters the lab pipeline. Manufacturers today usually supply uracil for analysis, molecular biology, and pharmaceutical needs, with packaging often ranging from one gram glass vials up to bulk fiber drums, marked with product numbers and clear hazard labeling.
Uracil appears as a white, odorless crystalline solid. Its melting point sits near 335°C, high compared to many organic compounds, because of the tight hydrogen-bonding between ring nitrogens and oxygens in the lattice. Uracil dissolves well in warm water, giving researchers flexibility in preparing solutions for experiments. The molecule’s logP value comes in at −1.07, reflecting high water solubility and poor affinity for organic solvents. UV spectra show a maximum absorbance around 260 nm, helping labs use spectrophotometry to measure RNA content rapidly.
Standard references demand at least 99% purity for biochemical uracil. Products list tightly controlled ranges for heavy metals, residual solvents, and moisture. Labels show batch number, expiration date, storage information, and clear identifiers for regulatory standards. Allergen or contaminant warnings follow local requirements, and chemical safety data sheets accompany most shipments. Quality control labs run mass spectrometry or HPLC assays on customer’s behalf, confirming identity and purity batch by batch. Without tough specifications like these, downstream processes in RT-PCR or enzyme assays risk failure.
Chemists learned long ago to prepare uracil through the condensation of malic acid derivatives with urea, then ring closure and dehydration. More modern approaches use barbituric acid as a starting material, leveraging robust acid catalysis and careful heating. The bulk production today skips plants and yeast extractions due to cost and contamination risks. Purification usually follows via recrystallization from hot water; any tricky residue or discolored crude often signals the need for another pass or tighter control of pH and temperature. Analytical chemists check every finished batch for unwanted byproducts—like cytosine or thymine—that could throw off sensitive assays.
Uracil offers multiple access points for chemical modification. The 5-position carbon stands out for electrophilic substitution, allowing scientists to synthesize 5-fluorouracil and similar drugs. Halogenation, nitrosation, and methylation at this site dramatically alter uracil’s biological properties. Both nitrogens, N1 and N3, participate in tautomerization, which makes uracil a key model in nucleic acid research. In labs, uracil undergoes glycosylation to form uridine, linking sugar moieties through N1 for RNA incorporation. Chemically, the resonance stabilization of the ring gives some protection against harsh reagents, though exposure to strong bases can open the ring, breaking it down into smaller fragments.
Uracil appears under a handful of names in scientific catalogs: 2,4-dioxopyrimidine, pyrimidine-2,4(1H,3H)-dione, U, and sometimes just “RNA base U.” Chemists see it referenced in different systems—like CAS 66-22-8, EC Number 200-621-9—depending on regulatory frameworks. Drug manufacturers selling 5-fluorouracil refer back to uracil as the core scaffold. Synonyms exist in translations—uracile (French), uracilo (Spanish)—reminding us of its universal role in biochemistry worldwide.
Handling uracil poses minimal hazard. The powder may cause mild eye or respiratory irritation, so gloves, goggles, and dust masks often come standard in good lab practice. Spills clean up easily with water, and combustion forms carbon monoxide, carbon dioxide, and nitrogen oxides—typical for nitrogenous bases. Emergency protocols mirror those for other low-toxicity laboratory chemicals: prompt washing of skin or eyes, local ventilation, and spill containment. Disposal policies recommend dilution and drain-down following local laws, as uracil breaks down readily in municipal water treatment due to its natural origins and biological lability.
Molecular biologists use uracil as a key marker for finding RNA in cells, exploiting its absence from DNA (which uses thymine instead). Reverse transcriptase enzymes, fundamental to PCR diagnostics and viral RNA research, rely on uracil’s presence for accurate coding and copying of genes. Medical researchers have long focused on uracil’s modifications; derivatives like 5-fluorouracil underpin many chemotherapeutic agents, targeting cancer cell replication by corrupting RNA processing. Environmental scientists track uracil in soil and water, using its levels to monitor microbial communities and natural decomposition. Even plant scientists study uracil as a sign of viral infection and gene expression changes during stress, because its metabolic pathway shifts under drought, exposure to pathogens, and periods of rapid growth.
In academic and biotech labs, new applications of uracil continue to surface. Structural biologists study its hydrogen-bonding properties with high-resolution crystallography, learning how small tweaks change protein-DNA recognition. The field of synthetic biology regularly engineers enzymes to install or remove uracil bases in custom-built genomes. Analytical chemists push detection limits down to femtomole levels with laser- or fluorescence-based tools, expanding forensics and clinical diagnostics. Some groups work on biocatalytic recycling, finding ways to re-use uracil from industrial fermentation waste streams as a sustainable practice, supporting green chemistry goals and the circular economy.
Uracil itself shows very low toxicity in mammals. Animal studies dating back decades support a high oral LD50 in rodents, and adverse effects crop up only at extreme doses well beyond workplace exposure. Cells possess uracil-DNA glycosylase enzymes, cleaning up any accidental inclusion into DNA strands. Metabolic byproducts generally clear through urine or get recycled into other pyrimidine pools. The bigger risk comes from structurally similar analogs—like 5-fluorouracil—which get incorporated into both RNA and DNA, disrupting cell division and causing well-known side effects in cancer patients. Acute exposure to massive uracil doses can cause diarrhea, nausea, or headaches due to osmolality shifts, but daily handling in research and diagnostic settings rarely approaches these levels.
As genome editing and mRNA therapeutics start to reshape medicine, uracil’s place only grows. Researchers design uracil-rich guide RNAs to drive gene editing tools, expanding disease targets and improving specificity. Cancer therapy continues to adapt uracil analogs, tuning side chains for tailored dosing and reduced toxicity. In agriculture, genetically-modified crops express uracil-based resistance markers for rapid breeding decisions, saving time and boosting yields. Demand for high-purity uracil will likely expand, driven by rising adoption of RNA vaccines and diagnostics. As labs move away from petroleum-derived chemicals, fermentation-based uracil production using engineered bacteria may take on a starring role, supporting cleaner supply chains and lower carbon footprints. From my own perspective working in a research environment, uracil represents both a reliable workhorse and a window into evolutionary biochemistry—a classic small molecule whose possibilities keep widening as technology advances.
Uracil sometimes feels like the underdog of the genetics world. Most people don’t give it a second thought until someone brings up DNA and RNA in a high school classroom or a medical drama. Found in RNA instead of thymine, uracil plays a key role in storing and passing on genetic information. Its use goes way past academic biology or curiosity. My first tangent with uracil came during college biochem labs—I remember its tangy chemical aroma and the white, chalky powder that seemed plain, but changed the way I looked at genetics.
Uracil lays the foundation for a lot of genetic engineering work. Every time researchers need to create recombinant RNA or study gene expression, uracil winds up in the spotlight. Its base pairing with adenine allows scientists to model RNA behavior or design new mRNA vaccines. Take the COVID-19 vaccines: uracil forms part of the basic building blocks of these mRNA strands. Without it, those vaccines likely wouldn’t have come together so fast. I’ve watched grad students pipette uracil solutions late into the night, tweaking reactions to study how cells respond to new therapies.
Uracil derivatives show up in several medicines—5-fluorouracil treats cancer, attacking rapidly dividing cells. Not only does it target tumors, but it’s saved lives during skin, colon, and breast cancer treatment. Blood tests sometimes look for uracil levels to check if someone processes certain drugs correctly. Missed doses or the wrong metabolism of uracil-based drugs can cause treatment to backfire, harming the patient. I’ve seen doctors nervously wait for uracil readings before setting up chemotherapy schedules, knowing a single number might tip the balance between harm and healing.
Modern farming uses uracil in the lab and in the field. Researchers use uracil-tagged markers to help breed stronger plants or detect plant pathogens faster. This cuts down loss and leads to hardier crops that feed more people. Food scientists sometimes rely on uracil in DNA-based tests to trace contamination and keep the supply chain safer. The food in my refrigerator—whether vegetables, meat, or processed cheese—passes through a gauntlet of safety checks, made easier through genetic analysis that starts with uracil as a building block.
Making uracil in large quantities brings up questions about chemical safety and environmental impact. Chemical production leaves a footprint, sometimes producing waste or emissions that demand careful oversight. Researchers and manufacturers now explore greener methods to synthesize uracil, turning to biotechnology and yeast-based production to lower toxic byproducts. I remember reading about small startups trying to use engineered microbes for uracil production, creating a buzz in biotech circles about eco-friendly labs.
Uracil sits at the crossing point of genetics, medicine, farming, and food safety. It links big breakthroughs in science with outcomes we see at the doctor’s office or on our plates at dinner. Its story is one of science stepping off the page and into daily life, full of quiet revolutions most of us don’t even notice, but benefit from every single day.
Uracil draws attention mostly in labs and research papers, rather than in everyday medicine cabinets. People interested in it often want answers about how it's taken or what it does. The thing about uracil—this isn’t your average vitamin or over-the-counter remedy. It's a naturally-occurring base in RNA, the kind our bodies already build on their own, which starts to raise questions when someone wants to take it as a supplement or medication.
No clear, everyday use for uracil in healthy people shows up in medical guides. Most hospitals and clinics won’t hand it out like a cold pill. If it gets mentioned, it's often about its role in research or, sometimes, as part of cancer treatment protocols—though it’s not a frontline drug for that either. For someone seriously wondering about uracil as a medication, it's important to look at the real demand: people don’t often need extra uracil because the body makes enough through food metabolism.
The only setting where uracil administration pops up is in some chemotherapy approaches. Here, it works together with other compounds—such as tegafur and uracil combined—to affect how certain cancers respond to treatment. When used this way, uracil comes as a pill, taken by mouth under a doctor’s close eye. This isn’t something you’d find at the supplement store, and dosing depends on weighing risks and benefits for each person.
Adding any purified compound to your body without a solid reason brings risk. With uracil, most people have never heard of side effects from regular consumption, since foods contain its building blocks in safe amounts anyway. But as a purified pill, side effects from chemotherapy combinations—not uracil alone—have a track record that includes nausea, loss of appetite, or gut disturbances.
When sorting out questions about uracil, trusting only what a healthcare provider explains can save a lot of trouble. Popular media can make substances seem like magic bullets, but real benefits rarely match the hype of blog posts or supplement ads. Just because a compound shows up on a medical label doesn’t mean it’s right for everyone, or anyone, outside tested conditions. Studies published by the National Institutes of Health or the FDA outline that uracil finds almost no clinical use in the general population on its own.
Every once in a while, someone comes across an online source suggesting an at-home benefit from something like uracil, or suggesting “RNA supplements.” Scientific consensus doesn’t support these products. As of 2024, uracil as an ingredient in consumer supplements isn’t widely seen as helpful or safe.
In practical terms, anyone curious about uracil should bring up those questions with a pharmacist or doctor. Relevant concerns might focus more productively on ensuring a diet with balanced protein, vitamins, and other building blocks that support natural RNA synthesis—since that covers the body’s needs without hunting for rare or expensive compounds. For anyone actually facing medical situations involving uracil, clear instructions and ongoing monitoring from healthcare professionals always take priority.
Paying attention to widely-accepted standards and sticking to reliable, evidence-based medicine beats chasing down untested shortcuts. Investment in your health works best guided by people with direct clinical experience and up-to-date knowledge.
Uracil tends to show up in science classes and research journals more often than in a typical medicine cabinet. It belongs to the set of molecules that help make up RNA, the stuff that helps transfer genetic information into real action behind the scenes. Most people never need extra uracil—our bodies make just enough, naturally. Some researchers, though, experiment with it to study DNA, cancer treatments, or microbial activity.
Once uracil enters the picture as a supplement or study drug, the story changes. Too much uracil in the human body usually signals that something has gone wrong with metabolism, such as a problem in how cells break down nucleic acids. Without tight control, increased uracil levels may create a ripple effect. Those who have to take drugs related to uracil derivatives, like fluorouracil in cancer therapy, soon learn about potential trouble. Doctors carefully monitor these drugs for a reason.
I remember a close friend facing cancer treatment. Chemo drugs based on uracil attacked fast-growing tumor cells, but they didn’t always spare healthy ones. The main side effects people spot are nausea, mouth sores, diarrhea, and changes in liver function. More severe cases lead to low white blood cell counts, which can weaken the immune defense. Damage to healthy tissues shows up too—think irritation in the stomach or gut, because cells there also grow and divide rapidly.
Fatigue gets overlooked in the world of side effects, but it ends up as one of the tougher issues for many. People have described how days seem harder to get through, meals lose their taste, and a general sense of fog sets in. Others report hair thinning or loss, driven by these drugs interfering with cell growth. Eyes and skin can see changes too, including redness, increased sensitivity, or even allergic reactions in rare cases.
Anyone with a background in genetics or lab work will tell you that uracil doesn’t stay isolated. The body’s ability to break down medications—thanks to a gene called DPD (dihydropyrimidine dehydrogenase)—shapes the risk. Low DPD activity means that drugs like fluorouracil, which rely on uracil metabolism, stick around longer and hit harder. In those situations, even standard doses can snowball into toxicity. Signs might show up as severe mouth ulcers, uncontrollable vomiting, or confusion.
People facing uracil-based therapies or research trials benefit from practical support. Bloodwork should be routine, not rare, to catch problems early. Screening for DPD deficiency can steer doctors to adjust plans, sparing patients unnecessary risk. Hydration, gentle foods, and rest matter just as much as complicated medical terms.
Doctors, nurses, and pharmacists can make a real difference by listening and acting on even mild complaints. Patients shouldn’t have to tough it out in silence—open conversations around fatigue, mouth pain, or stomach upset often lead to solutions, such as dose changes or new supportive medications. Research keeps chipping away at safer approaches, but thoughtful care, awareness, and prompt action remain the most powerful tools in the meantime.
Uracil doesn’t land in conversations often outside chemistry labs, but this simple molecule holds a big spot in biology. It’s one of the four nucleobases in RNA, acting as an information carrier in all living things. In the world of medicine, uracil sometimes finds a place as part of more complex drugs, especially certain cancer treatments and antiviral agents.
Walk up to any pharmacy counter and ask for uracil, and you’ll probably get a confused look. The pharmacist might even offer a lesson: pure uracil isn’t a product they stock for common ailments. Pharmacies don’t hand out uracil tablets over the counter. You’ll find uracil woven into specific medicines, like tegafur-uracil, which is prescribed for some cancers. This combination isn’t casual business. These drugs work at the core of cell growth and division, so doctors carefully decide who gets them and at what dose.
In the United States, uracil on its own isn’t sold as a drug. Medicines that use uracil as an ingredient—for example, to manage cancer—sit solidly behind the prescription counter. The Food and Drug Administration keeps a close eye on these formulations because messing with genetic material isn’t something you risk for minor aches. European and Asian regulators tend to echo these guidelines. You can’t pick up uracil-based medicines by walking into a drugstore or searching online pharmacies; a doctor’s decision guides that route from start to finish.
Cancer drugs that contain uracil work by manipulating DNA and RNA to interrupt cell division. These aren’t cures for headaches or insomnia—misused, they can cause permanent damage or life-threatening complications. Side effects draw a long list: immune suppression, changes to blood counts, and serious stomach problems all headline the warnings. This isn’t information most people can sift through alone. Healthcare professionals spend years learning how to weigh the risks and benefits. A prescription system creates a filter against misuse and keeps the treatment focused where it belongs.
I’ve watched families hunt desperately for last-ditch cures when a loved one faces cancer. Some search for miracle pills online, hoping to find something outside what their doctor prescribes. These websites often sell unregulated or counterfeit versions of drugs, and quality control flies out the window. In places where access to medicines isn’t tightly regulated, black markets thrive, putting already vulnerable patients in even more danger. Prescription control acts like a shield against these risks, even if waiting for approval from a specialist feels painfully slow.
Medicine’s job reaches beyond stopping disease; it’s about respect for the unknown. That’s why government oversight doesn’t let uracil drift into public hands unchecked. Yet, breaks in the chain can frustrate those in need. Digital health records and more streamlined referral systems might help connect patients with the right oncology or infectious disease experts faster. Capital investment in clinical pharmacist education can also empower pharmacists to better explain why some drugs require strict handling. Finally, continued research into safer versions of RNA-modifying drugs could one day lower risks, easing these rules for future treatments.
Uracil appears in biology textbooks as one of the four building blocks for RNA. Unlike thymine found in DNA, uracil slips into RNA to help carry genetic instructions around cells and trigger the steps of protein synthesis. In research labs and medical projects, pure uracil or uracil-based drugs sometimes play a more direct role. Handling these chemicals isn't always straightforward, and small mistakes can cause real setbacks.
Gloves and eye protection always hang near my bench. Uracil dust, like many fine chemicals, can irritate skin or eyes. It doesn’t have a strong smell that warns you of spills or airborne particles, so wearing a lab coat and keeping containers closed keeps exposure down. If a spill does happen, staring at the mess and wishing it would clean itself doesn’t solve anything—grab the spill kit, ventilate the room if possible, and call for help if the mess spreads.
Uracil powder prefers cool, dry, and dark conditions. Heat or light can break it down over time. I've seen bottles left near windows clump up and lose their original look within weeks. That’s a warning to any lab tech storing chemicals near benches or open shelving. Keep uracil away from acids, oxidizing agents, or moisture-heavy spots—chemical reactions that look minor can sometimes ruin expensive batches or release harmful fumes.
Swallowing uracil rarely happens in daily life, but breathing in dust or letting it touch mucus membranes leads to headaches, irritation, or allergic reactions in some cases. There’s also risk when uracil forms the basis for certain drugs. Capecitabine and 5-fluorouracil, two cancer medications built from uracil, can cause bone marrow suppression or mouth sores. That means those administering these drugs double-check dosages and patient responses during treatment.
Labs need plans for getting rid of leftover uracil. Dumping powder or washing it down the sink leads to local water issues if everyone did it. Collected waste should go in the right chemical disposal container, labeled clearly, and sent off for proper treatment. The local guidelines always tell you where those bins should wait until pickup.
Some projects fall apart simply because the uracil was old, contaminated, or mixed up with other white powders. Checking certificates of analysis, batch records, and expiry dates keeps experiments consistent. Analytical chemists often run a quick spectrometry or melting point check before using a new batch.
Clinical pharmacists, toxicologists, and research supervisors stay updated on guidelines for handling nucleic acid materials. Anyone nervous about a new protocol or unsure about a side effect can ask a registered pharmacist or medical liaison for current advice. This helps people make safe choices—not just follow instructions on a label.
Uracil opens the door to powerful therapies and essential cell studies, but rushing through handling or skipping safety steps just isn’t worth the risk. Paying close attention to how and where it’s stored, handled, and disposed of protects not only the people at the bench but everyone connected to their work.
| Names | |
| Preferred IUPAC name | pyrimidine-2,4(1H,3H)-dione |
| Other names |
2,4-Dioxypyrimidine Pyrimidine-2,4(1H,3H)-dione |
| Pronunciation | /ˈjʊərəˌsɪl/ |
| Identifiers | |
| CAS Number | 66-22-8 |
| Beilstein Reference | 50552 |
| ChEBI | CHEBI:17568 |
| ChEMBL | CHEMBL1357 |
| ChemSpider | 975 |
| DrugBank | DB03415 |
| ECHA InfoCard | 100.003.461 |
| EC Number | EC 2.4.2.21 |
| Gmelin Reference | 63534 |
| KEGG | C00106 |
| MeSH | D014509 |
| PubChem CID | 1174 |
| RTECS number | YQ0525000 |
| UNII | 44A6B0X59H |
| UN number | 2811 |
| Properties | |
| Chemical formula | C4H4N2O2 |
| Molar mass | 112.08676 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.32 g/cm³ |
| Solubility in water | Moderately soluble |
| log P | -1.07 |
| Vapor pressure | 1.72E-7 mmHg at 25°C |
| Acidity (pKa) | 9.5 |
| Basicity (pKb) | 12.15 |
| Magnetic susceptibility (χ) | -77.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.570 |
| Dipole moment | 4.80 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 146.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -589.1 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -2763 kJ/mol |
| Pharmacology | |
| ATC code | L01BC02 |
| Hazards | |
| Main hazards | Harmful if swallowed or inhaled; may cause respiratory tract irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319 |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | NFPA 704: 1-0-0 |
| Autoignition temperature | 410 °C (770 °F; 683 K) |
| Lethal dose or concentration | Lethal dose or concentration: LD50 oral rat 14,600 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 11 g/kg |
| NIOSH | SN1575000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for URACIL: Not established |
| REL (Recommended) | 10 mg/kg |
| Related compounds | |
| Related compounds |
Thymine Cytosine Uridine Uridine monophosphate 5-Fluorouracil |
